1. FDA Loophole Exploited to Bury Failed Pharma Trials
Pharmaceutical giants are systematically exploiting the FDA’s Accelerated Approval pathway to shield lucrative drugs from market withdrawal, internal regulatory communications reveal. Companies are granted early approval based on surrogate endpoints, with a strict mandate to conduct post-market confirmatory trials. How...